Kimoto Takafumi, Miura Daishiro
Toxicology Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino, 191-8512, Tokyo, Japan.
Methods Mol Biol. 2017;1641:161-172. doi: 10.1007/978-1-4939-7172-5_8.
Detection of in vivo mutation is important for evaluating the health risks associated with chemicals. The Pig-a in vivo gene mutation assay has been developed over the last decade for this purpose. Most approaches for the assay, however, measure cells with a Pig-a mutant phenotype in erythrocytes from the peripheral blood, with the mutations causing the phenotype being difficult to determine directly. This chapter describes a procedure for detecting mutations in the Pig-a gene of phenotypically mutant mouse bone marrow erythroids, the precursors of peripheral blood erythrocytes. The strategy for molecular analysis of Pig-a gene mutation includes enrichment of GPI-anchor deficient cells with a cell sorter followed by a cloning and sequencing of Pig-a cDNAs.
检测体内突变对于评估与化学物质相关的健康风险很重要。在过去十年中,为此目的开发了Pig-a体内基因突变试验。然而,该试验的大多数方法是检测外周血红细胞中具有Pig-a突变表型的细胞,而导致该表型的突变难以直接确定。本章描述了一种检测外周血红细胞前体表型突变小鼠骨髓红细胞中Pig-a基因突变的方法。Pig-a基因突变的分子分析策略包括用细胞分选仪富集缺乏糖基磷脂酰肌醇(GPI)锚的细胞,然后对Pig-a cDNA进行克隆和测序。